1.5 Abstract in rivista

1.5 Abstract in rivista: [2151] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.941 a 1.960 di 2.151

Increased tolerance to forearm ischemia-reperfusion in patients with type 1 diabetes mellitus

2005-01-01 Engbersen, R; Oyen, W; Meijer, P; Tack, Cj; Smits, P; Rongen, Ga

Bevacizumab prevents effective targeting of anti-epidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies

2012-01-01 Heskamp, S; van Laarhoven, Hwm; Molkenboer-Kuenen, Jdm; van der Graaf, Wta; Oyen, W; Boerman, Oc

Comparison of multiple (semi-)automatic segmentation methods for delineation of head and neck tumours in repetitive FLT-PET/CT imaging

2012-01-01 Arens, Aij; Troost, Egc; Hoeben, Baw; Grootjans, W; Maessen, Aw; Huisman, K; Lee, Ja; Visvikis, D; Bussink, J; Oyen, W; Kaanders, Jham; Visser, Ep

Quantification of the Pancreatic Beta Cell Mass with (111)Inexendin in Patients with Type 1 Diabetes and Healthy Controls

2013-01-01 van der Weg, W; Brom, M; Janssen, Mjr; Behe, M; Oyen, W; Tack, Cjj; Boerman, Oc; Gotthardt, M

SPECT/fluorescence dual-modality imaging of carcinoembryonic antigen-expressing tumors: a pretargeting study

2013-01-01 Rijpkema, M; Sharkey, R; Bos, D; Mcbride, W; Oyen, W; Goldenberg, D; Boerman, O

Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules

2013-01-01 Vriens, D; Adang, Emm; Netea-Maier, Rt; Smit, Jwa; de Wilt, Jhw; Oyen, W; de Geus-Oei, Lf

Dynamics of IGF-1R expression during endocrine breast cancer treatment

2013-01-01 Heskamp, S; Boerman, Oc; Molkenboer-Kuenen, Jdm; Oyen, W; van der Graaf, Wta; van Laarhoven, Hwm

SPECT/CT Imaging of Programmed-Death Ligand 1 Expression of Tumors and Antigen-Presenting Cells

2015-01-01 Heskamp, S; Hobo, W; Molkenboer-Kuenen, Jdm; Olive, D; Oyen, W; Dolstra, H; Boerman, Oc

PET and SPECT imaging of rheumatoid arthritis with radiolabeled anti-FAP antibody correlates with severity of arthritis

2014-01-01 Laverman, P; Gerrits, D; van der Geest, T; Koenders, M; Nayak, T; Freimoser-Grundschober, A; Klein, C; Oyen, W; Boerman, O

Pharmacokinetic analysis of tumor heterogeneity using FDG-PET

2010-01-01 Vriens, D; de Geus-Oei, Lf; Oyen, W; Visser, E

TRANSIENT STOP-FLOW ARM ARTERIAL-VENOUS EQUILIBRIUM PRESSURE MEASUREMENT: DETERMINATION OF PRECISION OF THE TECHNIQUE

2014-01-01 Aya, Hd; Rhodes, A; Fletcher, N; Grounds, M; Cecconi, M

The role of FDG-pet in the selection of patients with colorectal liver metastases

2007-01-01 Ruers, V; Wiering, B; Dekker, H; Krabbe, P; Oyen, W

THERE IS NO ADDITIONAL ROLE FOR ELT-PET/CT SCAN IN PEDIATRIC BRAINSTEM TUMORS

2010-01-01 Janssens, Gorj; Gidding, Cem; van Lindert, Ej; Schieving, J; Oyen, W

Radioimmunotherapy of advanced renal cell carcinoma patients with Lutetium-177 labeled monoclonal antibody cG250

2007-01-01 Oosterwijk, E; Stillebroer, A; Boerman, Oc; De Weijer, Kjm; Hendrickx, Bw; Oyen, W; Mulders, Pfa

Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer

2014-01-01 Lutje, S; Rijpkema, M; Goldenberg, Dm; Sharkey, Rm; Mcbride, Wj; Franssen, G; Frielink, C; van Rijl, C; Helfrich, W; Oyen, W; Boerman, Oc

Effect of Optimal Respiratory Gated Positron Emission Tomography on Clinical Staging and Management of Patients with Primary Lung Cancer

2014-01-01 Grootjans, W; Hermsen, R; Vriens, D; Visser, Ep; Oyen, W; de Geus-Oei, Lf

THE EFFECT OF A MEDICAL DEVICE CONTAINING HYALURONIC ACID, CHONDROITIN SULFATE AND ALUMINUM HYDROXIDE COMBINED WITH ACID SUPPRESSION IN THE TREATMENT OF THE EXTRA-ESOPHAGEAL SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE: PRELIMINARY DATA FROM A PROSPECTIVE, PARALLEL-GROUP RANDOMIZED CONTROLLED STUDY.

2019-01-01 Pellegatta, G; Semeraro, R; Mangiavillano, B; Auriemma, F; Cappello, A; D'Amico, F; Finati, E; Ferrara, Ec; Maselli, R; Di Leo, M; Fugazza, A; Galtieri, Pa; Belletrutti, Pj; Carrara, S; Anderloni, Aa; Repici, A

Dynamic FDG PET in liver metastases of colorectal cancer: repeatability of dynamic and static FDG PET parameters.

2013-01-01 Heijmen, L; van Laarhoven, Hwm; de Wilt, Jw; Bussink, J; Oyen, W; Visser, Ep; de Geus-Oei, L

Morphology of tumour-associated macrophages dictates the prognosis of patients with colorectal liver metastases

2019-01-01 Donadon, M; Di Tommaso, L; Cortese, N; Soldani, C; Franceschini, B; Carriero, R; Barbagallo, M; Rigamonti, A; Anselmo, A; Colombo, F; Maggi, G; Roncalli, M; Torzilli, G; Mantovani, A; Marchesi, F

Serum isoform [-2]proPSA (p2PSA) and its derivates, %p2PSA and PHI (prostate health index), are more accurate than the reference standard test (PSA) in men scheduled for repeat biopsy

2012-01-01 Lazzeri, M; Lughezzani, G; Larcher, A; Gadda, G; Scattoni, V; Sangalli, M; Nava, L; Bini, V; Maga, T; Bellinzoni, P; Cestari, A; Rigatti, P; Guazzoni, G

Titolo	Data di pubblicazione	Autore(i)
Increased tolerance to forearm ischemia-reperfusion in patients with type 1 diabetes mellitus	1-gen-2005	Engbersen, R; Oyen, W; Meijer, P; Tack, Cj; Smits, P; Rongen, Ga
Bevacizumab prevents effective targeting of anti-epidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies	1-gen-2012	Heskamp, S; van Laarhoven, Hwm; Molkenboer-Kuenen, Jdm; van der Graaf, Wta; Oyen, W; Boerman, Oc
Comparison of multiple (semi-)automatic segmentation methods for delineation of head and neck tumours in repetitive FLT-PET/CT imaging	1-gen-2012	Arens, Aij; Troost, Egc; Hoeben, Baw; Grootjans, W; Maessen, Aw; Huisman, K; Lee, Ja; Visvikis, D; Bussink, J; Oyen, W; Kaanders, Jham; Visser, Ep
Quantification of the Pancreatic Beta Cell Mass with (111)Inexendin in Patients with Type 1 Diabetes and Healthy Controls	1-gen-2013	van der Weg, W; Brom, M; Janssen, Mjr; Behe, M; Oyen, W; Tack, Cjj; Boerman, Oc; Gotthardt, M
SPECT/fluorescence dual-modality imaging of carcinoembryonic antigen-expressing tumors: a pretargeting study	1-gen-2013	Rijpkema, M; Sharkey, R; Bos, D; Mcbride, W; Oyen, W; Goldenberg, D; Boerman, O
Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules	1-gen-2013	Vriens, D; Adang, Emm; Netea-Maier, Rt; Smit, Jwa; de Wilt, Jhw; Oyen, W; de Geus-Oei, Lf
Dynamics of IGF-1R expression during endocrine breast cancer treatment	1-gen-2013	Heskamp, S; Boerman, Oc; Molkenboer-Kuenen, Jdm; Oyen, W; van der Graaf, Wta; van Laarhoven, Hwm
SPECT/CT Imaging of Programmed-Death Ligand 1 Expression of Tumors and Antigen-Presenting Cells	1-gen-2015	Heskamp, S; Hobo, W; Molkenboer-Kuenen, Jdm; Olive, D; Oyen, W; Dolstra, H; Boerman, Oc
PET and SPECT imaging of rheumatoid arthritis with radiolabeled anti-FAP antibody correlates with severity of arthritis	1-gen-2014	Laverman, P; Gerrits, D; van der Geest, T; Koenders, M; Nayak, T; Freimoser-Grundschober, A; Klein, C; Oyen, W; Boerman, O
Pharmacokinetic analysis of tumor heterogeneity using FDG-PET	1-gen-2010	Vriens, D; de Geus-Oei, Lf; Oyen, W; Visser, E
TRANSIENT STOP-FLOW ARM ARTERIAL-VENOUS EQUILIBRIUM PRESSURE MEASUREMENT: DETERMINATION OF PRECISION OF THE TECHNIQUE	1-gen-2014	Aya, Hd; Rhodes, A; Fletcher, N; Grounds, M; Cecconi, M
The role of FDG-pet in the selection of patients with colorectal liver metastases	1-gen-2007	Ruers, V; Wiering, B; Dekker, H; Krabbe, P; Oyen, W
THERE IS NO ADDITIONAL ROLE FOR ELT-PET/CT SCAN IN PEDIATRIC BRAINSTEM TUMORS	1-gen-2010	Janssens, Gorj; Gidding, Cem; van Lindert, Ej; Schieving, J; Oyen, W
Radioimmunotherapy of advanced renal cell carcinoma patients with Lutetium-177 labeled monoclonal antibody cG250	1-gen-2007	Oosterwijk, E; Stillebroer, A; Boerman, Oc; De Weijer, Kjm; Hendrickx, Bw; Oyen, W; Mulders, Pfa
Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer	1-gen-2014	Lutje, S; Rijpkema, M; Goldenberg, Dm; Sharkey, Rm; Mcbride, Wj; Franssen, G; Frielink, C; van Rijl, C; Helfrich, W; Oyen, W; Boerman, Oc
Effect of Optimal Respiratory Gated Positron Emission Tomography on Clinical Staging and Management of Patients with Primary Lung Cancer	1-gen-2014	Grootjans, W; Hermsen, R; Vriens, D; Visser, Ep; Oyen, W; de Geus-Oei, Lf
THE EFFECT OF A MEDICAL DEVICE CONTAINING HYALURONIC ACID, CHONDROITIN SULFATE AND ALUMINUM HYDROXIDE COMBINED WITH ACID SUPPRESSION IN THE TREATMENT OF THE EXTRA-ESOPHAGEAL SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE: PRELIMINARY DATA FROM A PROSPECTIVE, PARALLEL-GROUP RANDOMIZED CONTROLLED STUDY.	1-gen-2019	Pellegatta, G; Semeraro, R; Mangiavillano, B; Auriemma, F; Cappello, A; D'Amico, F; Finati, E; Ferrara, Ec; Maselli, R; Di Leo, M; Fugazza, A; Galtieri, Pa; Belletrutti, Pj; Carrara, S; Anderloni, Aa; Repici, A
Dynamic FDG PET in liver metastases of colorectal cancer: repeatability of dynamic and static FDG PET parameters.	1-gen-2013	Heijmen, L; van Laarhoven, Hwm; de Wilt, Jw; Bussink, J; Oyen, W; Visser, Ep; de Geus-Oei, L
Morphology of tumour-associated macrophages dictates the prognosis of patients with colorectal liver metastases	1-gen-2019	Donadon, M; Di Tommaso, L; Cortese, N; Soldani, C; Franceschini, B; Carriero, R; Barbagallo, M; Rigamonti, A; Anselmo, A; Colombo, F; Maggi, G; Roncalli, M; Torzilli, G; Mantovani, A; Marchesi, F
Serum isoform [-2]proPSA (p2PSA) and its derivates, %p2PSA and PHI (prostate health index), are more accurate than the reference standard test (PSA) in men scheduled for repeat biopsy	1-gen-2012	Lazzeri, M; Lughezzani, G; Larcher, A; Gadda, G; Scattoni, V; Sangalli, M; Nava, L; Bini, V; Maga, T; Bellinzoni, P; Cestari, A; Rigatti, P; Guazzoni, G

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.941 a 1.960 di 2.151

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext2098
reserved51
open2